According to our research analysis, Asia Pacific blood culture tests market 2021-2031 will grow by 9.7% annually with a total addressable market cap of USD 16.74 billion over 2022-2031 owing to the rising prevalence of bloodstream infections, increasing number of sepsis cases and high cost of treatment, rising geriatric population, and the rising demand for rapid diagnostic techniques amid the COVID-19 pandemic.
Highlighted with 32 tables and 54 figures, this 110-page report Asia Pacific Blood Culture Tests Market 2021-2031 by Product (Consumables, Instruments, Software and Services), Method (Conventional, Automated), Technology (Culture-Based, Molecular, Proteomics, Others), Application (Bacteremia, Fungemia, Mycobacterial Detection), End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific blood culture tests market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific blood culture tests market in every aspect of the classification from perspectives of Product, Method, Technology, Application, End User, and Country.
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD Mn) for 2021-2031 included in each section.
- Consumables
- Blood Culture Media
- Assay Kits & Reagents
- Blood Culture Accessories
Instruments
- Automated Blood Culture Systems
- Supporting Laboratory Equipment
Software and Services
Based on Method, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD Mn) for 2021-2031 included in each section.
- Conventional/Manual Methods
- Automated Methods
Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD Mn) for 2021-2031 included in each section.
- Culture-Based Technologies
- Molecular Technologies
- Microarrays
- Polymerase Chain Reaction (PCR)
- PNA-FISH
Proteomics Technology
Other Technologies
Request for Sample Report @
https://kenresearch.com/sample-report.php?Frmdetails=NTE1MTgw
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD Mn) for 2021-2031 included in each section.
- Bacteremia
- Fungemia
- Mycobacterial Detection
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD Mn) for 2021-2031 included in each section.
- Hospital Laboratories
- Reference Laboratories
- Academic Research Laboratories
For More Information, refer to below link: –
Asia Pacific Blood Culture Tests Market Growth Rate
Related Report:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us: –
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
